EVALUATION OF THE ROLE OF D-DIMER, FERRITIN PARAMETERS IN THE PROGNOSIS OF COVID-19 PATIENTS
Main Article Content
Abstract
Background: COVID-19 has spread worldwide from December 2019 to the present. Many biological markers have been used to predict poor outcomes, contributing to early detection and improving patient management.
Objective: To evaluate the role of D-dimer and Ferritin parameters in predicting the severity of COVID-19 patients.
Methods: Cross-sectional descriptive design combined with a prospective study on 293 patients with positive RT-PCR results for SARS-CoV-2 at Military Hospital 7A; Demographic characteristics, vaccination history, underlying disease, and laboratory parameters including D-dimer and ferritin were collected. Patients were divided into two groups based on disease severity: mild group (n=208), and severe group (n=85).
Results: The median age of the study population was 49 (34-62), with 50.9% were male patients. The severe COVID-19 group had significantly higher ferritin and d-dimer levels compared to the mild COVID-19 group. ROC curve analysis, serum Ferritin concentration ≥ 602.5 Microg/L predicted severe COVID-19 with a sensitivity of 68.2% and specificity of 90.9%.
Conclusion: Early Ferritin analysis in COVID-19 patients could effectively predict the severity of the disease.
Keywords
COVID-19, SARS-CoV2, D-dimer, Ferritin
Article Details
References
Richardson, S., et al., Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama, 2020. 323(20): p. 2052-2059.
Chen, N., et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020. 395(10223): p. 507-513.
Joshi, S., et al., Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India. Emerg Infect Dis, 2022. 28(1): p. 1-8.
Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. International Journal of Infectious Diseases: IJID: official publication of the International Society for Infectious Diseases. Jun 2020;95:304-307. doi:10.1016/j. ijid.2020.04.061
Cheng L, Li H, Li L, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. Oct 2020;34(10):e23618. doi:10.1002/jcla.23618
Zhou, F., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020. 395(10229): p. 1054-1062.
Li, Y., et al., Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab Invest, 2020. 100(6): p. 794-800.